TiumBio Co., Ltd. (KOSDAQ:321550)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,230.00
0.00 (0.00%)
At close: Feb 19, 2026

TiumBio Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
7,12516,45410,50918,1306,8803,463
Short-Term Investments
9,500-03,000-33,75540,000
Trading Asset Securities
28,64434,17026,94816,970-25,113
Cash & Short-Term Investments
45,26950,62440,45735,10040,63568,576
Cash Growth
116.80%25.13%15.26%-13.62%-40.74%-22.85%
Accounts Receivable
794.55743.01537.3990.823.44544
Other Receivables
827.66526.39633.93369.93943.81164.5
Receivables
1,6511,3181,171460.73967.24708.5
Inventory
461.32356.06----
Prepaid Expenses
89.1394.98201.24182.85136.88157.83
Other Current Assets
8,3356,5203,4814,551161.96409.06
Total Current Assets
55,80658,91445,31140,29541,90169,851
Property, Plant & Equipment
44,03944,72142,03124,36214,8262,682
Long-Term Investments
899.99899.9923,31124,57946,09410,411
Goodwill
1,3261,326----
Other Intangible Assets
441.73423.44584.691,0721,3241,705
Other Long-Term Assets
931.591,0148,3095,95112,591702.51
Total Assets
103,445107,298119,54696,259116,73585,351
Accounts Payable
130.0968.65----
Accrued Expenses
2,8832,9992,4611,9702,5371,339
Short-Term Debt
12,57912,9674,86919,133--
Current Portion of Leases
963.53532.26895.1516.79850.28317.93
Current Unearned Revenue
483.0976.2316.1143.6525.154.15
Other Current Liabilities
9,37810,8184,4998,4461,054115.67
Total Current Liabilities
28,66727,46113,04130,1104,4671,777
Long-Term Debt
20,24116,40022,6552,70817,787-
Long-Term Leases
920.53280.16580.61853.14836.94931.16
Long-Term Unearned Revenue
-48.8786.12130.53140.2973.84
Long-Term Deferred Tax Liabilities
326.34326.34----
Other Long-Term Liabilities
4,724143.332,031170.873,18563.16
Total Liabilities
54,87844,65938,39333,97226,4162,845
Common Stock
13,57213,35612,47512,00911,95911,892
Additional Paid-In Capital
46,160169,920169,084145,553144,535110,895
Retained Earnings
-32,240-141,848-121,204-103,293-73,413-41,776
Comprehensive Income & Other
9,7669,7158,1686,0903,8041,495
Total Common Equity
37,25951,14368,52260,35986,88482,507
Minority Interest
-2,742-1,713296.331,2492,746-
Shareholders' Equity
48,56662,63981,15362,28790,31982,507
Total Liabilities & Equity
103,445107,298119,54696,259116,73585,351
Total Debt
36,95430,18029,00023,21119,4741,249
Net Cash (Debt)
8,31520,44411,45711,88921,16167,327
Net Cash Growth
-78.44%-3.63%-43.82%-68.57%-24.15%
Net Cash Per Share
313.02791.37469.70496.13888.582866.51
Filing Date Shares Outstanding
27.1426.7124.9524.0223.9223.78
Total Common Shares Outstanding
27.1426.7124.9524.0223.9223.78
Working Capital
27,13931,45332,27010,18537,43468,075
Book Value Per Share
1372.581914.602746.482513.073632.693469.01
Tangible Book Value
35,49149,39467,93859,28785,56080,802
Tangible Book Value Per Share
1307.461849.112723.052468.433577.353397.32
Land
14,85614,85612,783---
Buildings
19,04119,04117,510---
Machinery
15,71215,79414,16111,4698,1961,792
Construction In Progress
-44.8-14,2755,415-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.